Sollinda Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Buy
1,451
+195
+16% +$45.4K 0.08% 53
2026
Q1
$307K Sell
1,256
-20
-2% -$4.66K 0.07% 61
2025
Q4
$264K Sell
1,276
-386
-23% -$76.3K 0.07% 65
2025
Q3
$308K Sell
1,662
-32
-2% -$5.48K 0.08% 56
2025
Q2
$259K Buy
1,694
+29
+2% +$4.46K 0.07% 79
2025
Q1
$276K Buy
+1,665
New +$261K 0.08% 54
2024
Q4
Sell
-1,305
Closed -$211K 72
2024
Q3
$211K Buy
+1,305
New +$208K 0.06% 60
2024
Q1
Sell
-29,734
Closed -$4.66M 74
2023
Q4
$4.66M Buy
+29,734
New +$4.56M 1.32% 12

Other funds holding JNJ

Sollinda Capital Management's JNJ Position: Q2 2026 in Review

Sollinda Capital Management increased its Johnson & Johnson (JNJ) stake by 16% in Q2 2026, buying an estimated $45.4K and bringing the position to 1,451 shares worth $368K. The position accounts for 0.08% of the portfolio, ranked #53.

Sollinda Capital Management first reported a position in JNJ in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.66M in Q4 2023. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sollinda Capital Management held 1,451 shares of Johnson & Johnson worth $368K as of Q2 2026.
  • Sollinda Capital Management bought 195 Johnson & Johnson shares in Q2 2026, an estimated $45.4K.
  • Johnson & Johnson made up 0.08% of Sollinda Capital Management's portfolio in Q2 2026, its #53 holding.
  • Sollinda Capital Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 8 quarters since.
  • Sollinda Capital Management's Johnson & Johnson position peaked at $4.66M in Q4 2023.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sollinda Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.